Clinical translation of mesenchymal stem cells in ischemic heart failure: Challenges and future perspectives.

 0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Lisa Alibrandi, Sanjiv Dhingra, Anqi Guan, Qingdong Guan, Vincenzo Lionetti, Niketa Sareen, Elika Verma

Ngôn ngữ: eng

Ký hiệu phân loại:

Thông tin xuất bản: United States : Vascular pharmacology , 2025

Mô tả vật lý:

Bộ sưu tập: NCBI

ID: 727024

Myocardial infarction (MI) with resulting congestive heart failure is one of the leading causes of death worldwide. Current therapies for treating MI, such as devices, traditional medicine, and surgeries, come with many limitations as patients in their final stages of heart failure have little chances of experiencing any reversible changes. In recent decades, Mesenchymal stem cell (MSC) based therapy has become one of the most popular and rapidly developing fields in treating MI. Their supremacy for clinical applications is partially due to their unique properties and encouraging pre-clinical outcomes in various animal disease models. However, the majority of clinical trials registered for MSC therapy for diverse human diseases, including MI, have fallen short of expectations. This review intends to discuss the recent advances in the clinical application of using MSCs for cardiac repair and discuss challenges facing the clinical translation of MSCs for cardiac regeneration such as restoration of endothelial-cardiomyocyte crosstalk, immunomodulation and immune rejection, poor homing and migration, as well as low retention and survival. Furthermore, we will discuss recent strategies being investigated to help overcome some of these challenges.
Tạo bộ sưu tập với mã QR

THƯ VIỆN - TRƯỜNG ĐẠI HỌC CÔNG NGHỆ TP.HCM

ĐT: (028) 36225755 | Email: tt.thuvien@hutech.edu.vn

Copyright @2024 THƯ VIỆN HUTECH